Artal Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-655,555
| Closed | -$26.8M | – | 75 |
|
|
2024
Q2 | $26.8M | Buy |
+655,555
| New | +$26.8M | 0.68% | 19 |
|
|
2023
Q4 | – | Sell |
-300,000
| Closed | -$1.91M | – | 105 |
|
|
2023
Q3 | $1.91M | Hold |
300,000
| – | – | 0.08% | 67 |
|
|
2023
Q2 | $3.33M | Sell |
300,000
-211,962
| -41% | -$2.35M | 0.1% | 71 |
|
|
2023
Q1 | $7.86M | Buy |
511,962
+11,962
| +2% | +$184K | 0.47% | 47 |
|
|
2022
Q4 | $11.1M | Buy |
500,000
+250,000
| +100% | +$5.55M | 0.62% | 35 |
|
|
2022
Q3 | $4.08M | Hold |
250,000
| – | – | 0.17% | 62 |
|
|
2022
Q2 | $3.63M | Hold |
250,000
| – | – | 0.19% | 70 |
|
|
2022
Q1 | $4.62M | Hold |
250,000
| – | – | 0.19% | 81 |
|
|
2021
Q4 | $5.94M | Buy |
250,000
+107,500
| +75% | +$2.56M | 0.16% | 90 |
|
|
2021
Q3 | $3.51M | Hold |
142,500
| – | – | 0.08% | 117 |
|
|
2021
Q2 | $3.52M | Hold |
142,500
| – | – | 0.07% | 120 |
|
|
2021
Q1 | $3.11M | Hold |
142,500
| – | – | 0.05% | 119 |
|
|
2020
Q4 | $3.64M | Hold |
142,500
| – | – | 0.08% | 107 |
|
|
2020
Q3 | $4.01M | Sell |
142,500
-32,500
| -19% | -$915K | 0.1% | 91 |
|
|
2020
Q2 | $4.95M | Buy |
+175,000
| New | +$4.95M | 0.14% | 92 |
|